Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Prostatype Genomics AB

Closing information (x1000 SEK)

Closing information 2023/12 (consolidated) 2022/12 2021/12
Turnover 1,356 Less Arrow 683 Less Arrow 10
Financial expenses 2,192 Less Arrow 396 Less Arrow 81
Earnings before taxes -41,435 More Arrow -29,087 More Arrow -15,630
EBITDA -37,372 More Arrow -26,786 More Arrow -15,460
Total assets 49,222 Less Arrow 30,950 More Arrow 40,203
Current assets 25,910 Less Arrow 14,169 More Arrow 21,585
Current liabilities 24,482 Less Arrow 4,332 Less Arrow 3,430
Equity capital 24,673 More Arrow 26,151 More Arrow 35,906
- share capital 7,168 Less Arrow 1,372 Less Arrow 905
Employees (average) 7 Less Arrow 6 Less Arrow 5

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 2021/12
Solvency 50.1% More Arrow 84.5% More Arrow 89.3%
Turnover per employee 194 Less Arrow 114 Less Arrow 2
Profit as a percentage of turnover -3055.7% Less Arrow -4258.7% Less Arrow -156300%
Return on assets (ROA) -79.7% Less Arrow -92.7% More Arrow -38.7%
Current ratio 105.8% More Arrow 327.1% More Arrow 629.3%
Return on equity (ROE) -167.9% More Arrow -111.2% More Arrow -43.5%
Change turnover
Change turnover % 6730% Less Arrow -99%
Chg. No. of employees
Chg. No. of employees % 20% Less Arrow 0%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.